| scholarly article | Q13442814 |
| P50 | author | Kristine Yaffe | Q18749055 |
| Hal Atkinson | Q87632378 | ||
| Lewis Kuller | Q88077314 | ||
| David C Goff | Q96109271 | ||
| Bruce M. Psaty | Q30429993 | ||
| Stephen B Kritchevsky | Q40122833 | ||
| Kaycee M Sink | Q56993455 | ||
| P2093 | author name string | Xiaoyan Leng | |
| Jeff Williamson | |||
| Sevil Yasar | |||
| Mike Robbins | |||
| P2860 | cites work | Alzheimer Disease in the US Population | Q22253055 |
| Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia | Q24246379 | ||
| Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288 | Q69132365 | ||
| Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs | Q69585210 | ||
| Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro | Q69693567 | ||
| Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors | Q69849046 | ||
| Hypertension and dementia | Q79165291 | ||
| Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition | Q80768190 | ||
| Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | Q29618529 | ||
| Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data | Q30744678 | ||
| Evaluation of dementia in the cardiovascular health cognition study | Q30766477 | ||
| Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial | Q31834521 | ||
| The Modified Mini-Mental State (3MS) examination | Q34185551 | ||
| Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis | Q34198795 | ||
| Effect of chronic treatment with trandolapril or enalapril on brain ACE activity in spontaneously hypertensive rats | Q34395406 | ||
| Pharmacological and clinical profile of moexipril: a concise review | Q34549738 | ||
| Neural plasticity and the brain renin-angiotensin system | Q34942174 | ||
| Does the angiotensin II receptor antagonist losartan improve cognitive function? | Q34975792 | ||
| Incidence and prevalence of dementia in the Cardiovascular Health Study | Q35631591 | ||
| The role of inflammation in Alzheimer's disease | Q35913633 | ||
| Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors. | Q38299970 | ||
| The relationship between blood pressure and dementia: a review | Q41695322 | ||
| Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia | Q43668225 | ||
| Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease | Q43787450 | ||
| The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study | Q44175666 | ||
| The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial | Q44417511 | ||
| Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease | Q44438340 | ||
| Inhibition of brain angiotensin-converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats | Q45308767 | ||
| Inflammatory markers and cognition in well-functioning African-American and white elders | Q46884320 | ||
| Age‐Related Decline in Spatial Learning and Memory: Attenuation by Captopril | Q47407724 | ||
| Acute and chronic effects of angiotensin-converting enzyme inhibitors on tissue angiotensin-converting enzyme | Q48598805 | ||
| Angiotensin-converting enzyme modulates dopamine turnover in the striatum | Q48793369 | ||
| Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study | Q48874950 | ||
| Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition | Q49130800 | ||
| Trends in hypertension prevalence, treatment, and control: in a well-defined older population. | Q50910135 | ||
| Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. | Q51982382 | ||
| Assessment and control for confounding by indication in observational studies. | Q52913031 | ||
| Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. | Q53224110 | ||
| Midlife blood pressure and dementia: the Honolulu-Asia aging study. | Q53234678 | ||
| Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan. | Q53261134 | ||
| Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. | Q53276432 | ||
| Statin Use and the Risk of Incident Dementia | Q57392350 | ||
| Antihypertensive drugs and incidence of dementia: the Rotterdam Study | Q57782073 | ||
| Assessment of older people: self-maintaining and instrumental activities of daily living | Q66829682 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| hypertension | Q95566669 | ||
| P304 | page(s) | 1195-1202 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study | |
| P478 | volume | 169 |
| Q35125374 | 'Hearts and minds': association, causation and implication of cognitive impairment in heart failure |
| Q34399201 | A Comparison of Cognitive and Everyday Functional Performance among Older Adults With and Without Hypertension |
| Q35428133 | A Longitudinal SPECT Study of Different Patterns of Regional Cerebral Blood Flow in Alzheimer's Disease with or without Diabetes |
| Q36847601 | A multi-center study of ACE and the risk of late-onset Alzheimer's disease |
| Q37198547 | A multicenter study of neurocognition in children with hypertension: methods, challenges, and solutions |
| Q37139242 | ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's disease |
| Q34310258 | ACE variants and association with brain Aβ levels in Alzheimer's disease |
| Q24317730 | Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme |
| Q36270062 | Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice |
| Q48550641 | Angiotensin Converting Enzyme Inhibitors Ameliorate Brain Inflammation Associated with Microglial Activation: Possible Implications for Alzheimer's Disease |
| Q42069122 | Angiotensin II-inhibiting drugs have no effect on intraneuronal Aβ or oligomeric Aβ levels in a triple transgenic mouse model of Alzheimer's disease. |
| Q42069095 | Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse. |
| Q37415248 | Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele |
| Q34364232 | Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele |
| Q35023755 | Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink |
| Q39356544 | Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort |
| Q36670162 | Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging |
| Q35564715 | Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms |
| Q34013528 | Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals |
| Q33867559 | Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer's disease |
| Q44889302 | B-type natriuretic peptide as a predictor of declining cognitive function and dementia--a cohort study of an elderly general population with a 5-year follow-up |
| Q49021624 | Binding of ACE-inhibitors to in vitro and patient-derived amyloid-β fibril models. |
| Q50771406 | Blood pressure responses to hypertension treatment and trends in cognitive function in patients with initially difficult-to-treat hypertension: a retrospective subgroup analysis of the Observational Study on Cognitive Function and SBP Reduction (OSC |
| Q95326104 | Blood-brain barrier dysfunction: the undervalued frontier of hypertension |
| Q38053075 | Brain renin-angiotensin system in the nexus of hypertension and aging |
| Q26741140 | Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient population |
| Q36057329 | Cerebral Perfusion Enhancing Interventions: A New Strategy for the Prevention of Alzheimer Dementia |
| Q38848257 | Chronic kidney disease-related physical frailty and cognitive impairment: a systemic review |
| Q89288249 | Clarifying dementia risk factors: treading in murky waters |
| Q36292056 | Cognition and Hemodynamics |
| Q41860101 | Comparative Effect of Lisinopril and Fosinopril in Mitigating Learning and Memory Deficit in Scopolamine-Induced Amnesic Rats. |
| Q38116974 | Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease |
| Q48553675 | Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats. |
| Q30419458 | Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory Study |
| Q30432845 | Drug delivery systems, CNS protection, and the blood brain barrier |
| Q36989228 | Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia |
| Q48891177 | Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease |
| Q38690145 | Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives |
| Q47810336 | Emotional function in dementia patients |
| Q48873920 | Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease |
| Q37094983 | Enalapril protects endothelial cells against induced apoptosis in Alzheimer's disease |
| Q35634758 | Evidence-Based Heart Failure Medications and Cognition. |
| Q36811092 | Heart disease as a risk factor for dementia |
| Q34318825 | Hyponatremia in a patient with scleroderma renal crisis: a potential role of activated renin-angiotensin system |
| Q39034947 | Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis |
| Q49030226 | Inhibition of the cerebral renin-angiotensin system to limit cognitive decline in elderly hypertensive persons |
| Q36576477 | Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease. |
| Q36373375 | Interactive effects of subjective memory complaints and hypertension on learning and memory performance in the elderly |
| Q50516923 | Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease. |
| Q36938427 | Low glial angiotensinogen improves body habitus, diastolic function, and exercise tolerance in aging male rats. |
| Q33604279 | Memory is preserved in older adults taking AT1 receptor blockers |
| Q36272118 | Microparticles shed from multidrug resistant breast cancer cells provide a parallel survival pathway through immune evasion |
| Q36551172 | Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease |
| Q36034402 | Neurocognitive alterations in hypertensive children and adolescents |
| Q34789487 | Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine. |
| Q52099112 | No Brain Renin-Angiotensin System: Déjà vu All Over Again? |
| Q48807054 | No association of angiotensin I converting enzyme I/D polymorphism with domain-specific cognitive function in aged men without dementia |
| Q37788825 | Non-adherence to antihypertensive medication and impaired cognition: which comes first? |
| Q37709571 | Novel strategies and targets for the management of hypertension |
| Q48400442 | Prevention of hypertension-induced vascular dementia by Lactobacillus paracasei subsp. paracasei NTU 101-fermented products |
| Q47908386 | Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial |
| Q28074637 | Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal Studies |
| Q46316918 | Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease |
| Q38108717 | Renin-angiotensin-aldosterone system has a pivotal role in cognitive impairment |
| Q64241947 | Sustained Captopril-Induced Reduction in Blood Pressure Is Associated With Alterations in Gut-Brain Axis in the Spontaneously Hypertensive Rat |
| Q55007046 | Targeting Renin-Angiotensin System Against Alzheimer's Disease. |
| Q36019970 | Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies |
| Q37255417 | The 2-minute step test is independently associated with cognitive function in older adults with heart failure |
| Q38256961 | The Cerebrovascular Basement Membrane: Role in the Clearance of β-amyloid and Cerebral Amyloid Angiopathy |
| Q52347539 | The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment? |
| Q34286911 | The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial. |
| Q35893991 | The relationship between blood pressure and cognitive function |
| Q28085528 | The renin-angiotensin system and prevention of age-related functional decline: where are we now? |
| Q38651269 | The renin-angiotensin system: a possible new target for depression |
| Q43495509 | Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors |
| Q36377901 | Treatment options and considerations for hypertensive patients to prevent dementia |
| Q34533985 | Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease |
| Q35195840 | Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study |
| Q42717822 | Use of renin-angiotensin system blockade in patients with renal artery stenosis |
| Q38095651 | Visual hallucinations related to angiotensin-converting enzyme inhibitor use: case reports and review |
| Q58609069 | [Arterial hypertension in old age with the focus on 80] |
| Q53324176 | [Prevention of vascular dementia. Evidence and practice]. |
Search more.